Financials
- Market Capitalization 1.99 B
- Employee 540
- Founded 2008
- CEO N/A
- Website www.agios.com
- Headquarter Delaware, United States
- FIGI BBG000QY4ZD0
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2007 | NBTX Nanobiotix S.A. - ADSs | 41.23 USD | -8.70% | +1.25% | +2.89% | +397.35% | 2.00 B USD | ||
| 2009 | MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 7.68 USD | -8.24% | -10.59% | +13.61% | +221.34% | 1.99 B USD | ||
| 2028 | XNCR Xencor, Inc. - Common Stock | 26.06 USD | -9.76% | -6.26% | +21.21% | +220.15% | 1.94 B USD | ||
| 2045 | IMCR Immunocore Holdings plc - American Depositary Shares | 36.62 USD | -0.35% | -0.38% | +7.71% | +9.38% | 1.89 B USD |
Frequently asked questions about Agios Pharmaceuticals, Inc.
What is the Agios Pharmaceuticals, Inc. stock price today?
The current price of Agios Pharmaceuticals, Inc. (AGIO) is 33.32. Over the past 24 hours, the stock has changed by -2.80%. Follow the AGIO chart for real-time price dynamics.
What is the stock ticker of Agios Pharmaceuticals, Inc.?
Agios Pharmaceuticals, Inc. trades under the ticker AGIO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Agios Pharmaceuticals, Inc. stock going up?
AGIO has changed by +0.21% over the last week, -0.06% over the last month, and -23.21% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Agios Pharmaceuticals, Inc.?
Agios Pharmaceuticals, Inc. currently has a market capitalization of 1.99 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Agios Pharmaceuticals, Inc. earnings last quarter?
Last quarter, Agios Pharmaceuticals, Inc. reported earnings of -1.69 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Agios Pharmaceuticals, Inc. revenue for the last quarter?
Agios Pharmaceuticals, Inc. reported quarterly revenue of 44.74 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Agios Pharmaceuticals, Inc. net income for the last quarter?
Agios Pharmaceuticals, Inc. reported net income of -100.7 M for the last quarter. The previous quarter showed -99.11 M, which means net income changed by -1.61%.
How many employees does Agios Pharmaceuticals, Inc. have?
As of the latest available data, Agios Pharmaceuticals, Inc. has 540 employees. Workforce size can provide additional context about the company's scale and operations.
What is Agios Pharmaceuticals, Inc. EBITDA?
Agios Pharmaceuticals, Inc. EBITDA is -110.33 M, and its EBITDA margin is -246.57%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Agios Pharmaceuticals, Inc. stock?
You can buy Agios Pharmaceuticals, Inc. (AGIO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Agios Pharmaceuticals, Inc. stock?
Investing in Agios Pharmaceuticals, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AGIO chart and related analysis on metatrader.com as part of your research.